Airsonett

Airsonett® is a Swedish medical device company that leads the way in the development of non-pharmacologic treatment of allergic severe asthma and eczema. Airsonett® Air4 is a non-invasive device for treatment in the home, based on the patented Temperature-controlled Laminar Airflow technology (TLA). Treatment with the Airsonett Air4 significantly reduces allergens and other airborne irritants from the patient’s breathing zone during rest and sleep. Airsonett Air4 is a CE marked class 1 medical device that meets the requirements according to MDR 2017/745, intended to be used for the alleviation of symptoms of allergy-induced diseases such as allergic asthma and eczema. Airsonett Air4 holds a 510(k) cleared class II approval from FDA. At Airsonett, we earn customer loyalty by developing, manufacture, market, and service TLA devices, of the highest quality and user value. At Airsonett we define quality as customer perceived value. Airsonett® Air4 is a medical device for effective home treatment of allergic asthma and eczema.